VNDA
Vanda Pharmaceuticals Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares +9.1% ·
flujo de acciones +3.9% ·
nuevas posiciones netas +8.3%
— fórmula
Acumulación amplia — aumento de acciones entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 76 | 0 | 37.76M | $231.07M | +7 | −7 |
| Q1 2026 | 78 | +6 | 33.85M | $233.91M | +14 | −8 |
| Q4 2025 | 72 | -1 | 30.64M | $270.14M | +1 | −2 |
| Q3 2025 | 17 | 0 | 25.97M | $129.59M | — | −1 |
| Q2 2025 | 15 | 0 | 24.58M | $116.00M | — | — |
| Q1 2025 | 12 | 0 | 9.69M | $44.48M | — | — |
| Q4 2024 | 12 | +1 | 8.66M | $41.48M | +1 | — |
| Q3 2024 | 10 | -1 | 7.15M | $33.54M | — | −1 |
| Q2 2024 | 11 | — | 6.99M | $39.47M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 3.85M | -3.9% | $18.46M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasivo) | 1.45M | +1.7% | $6.95M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasivo) | 1.45M | +1.7% | $6.95M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | State Street Global Advisors ✦ (pasivo) | 1.18M | — | $5.67M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Millennium Management ✦ | 668.69K | +67.4% | $3.20M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 381.08K | +167.6% | $1.83M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 381.08K | +167.6% | $1.83M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 348.85K | +12.7% | $1.67M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 348.85K | +12.7% | $1.67M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 304.15K | -45.7% | $1.46M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 304.15K | -45.7% | $1.46M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 199.46K | +94.7% | $955,413 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Norges Bank ✦ (pasivo) | 115.00K | 0.0% | $550,850 | 0.0% | Held | 3 | SEC ↗ |
| 14 | Marshall Wace ✦ | 80.80K | Nuevo | $387,032 | 0.0% | New | 1 | SEC ↗ |
| 15 | Marshall Wace ✦ | 80.80K | Nuevo | $387,032 | 0.0% | New | 1 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 49.98K | -24.2% | $239,400 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 49.98K | -24.2% | $239,400 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 49.98K | -24.2% | $239,400 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | T. Rowe Price ✦ | 22.27K | +17.8% | $107,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Marshall Wace | $387,032 | 0.0% |
| Marshall Wace | $387,032 | 0.0% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 168 tenedores, 45.91M acciones, $293.46M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.